Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Harvard University
- National University of Singapore
- University of British Columbia
- Indiana University
- City of Hope
- Dana-Farber Cancer Institute (DFCI)
- Nanyang Technological University
- UNIVERSITY OF HELSINKI
- University of Michigan
- King's College London
- Max Planck Institute for Human Development, Berlin
- The Ohio State University
- UiT The Arctic University of Norway
- University of California
- University of Maryland, Baltimore
- University of Oxford
- Zintellect
- ADELAIDE UNIVERSITY
- BU Pulmonary
- Cori Institute of Molecular and Computational Metabolism
- Eisbach Bio GmbH
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Humboldt-Universität zu Berlin
- Icelandic Heart Association
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- Lawrence Berkeley National Laboratory
- Margaret M Redfield
- Max Planck Institute of Biochemistry, Martinsried
- Mayo Clinic
- Monash University
- Northeastern University
- Research Center for Molecular Medicine (CeMM), ÖAW
- SciLifeLab
- Tampere University
- The University of Edinburgh;
- The University of Queensland
- Tokyo University of Science
- UT Health San Antonio Long School of Medicine
- University of Aberdeen;
- University of Birmingham
- University of Colorado
- University of Helsinki
- University of Leeds
- University of Michigan (U-M)
- University of Michigan - Ann Arbor
- University of New South Wales
- University of North Carolina at Charlotte
- University of Oklahoma Health Campus
- University of Oslo
- University of Otago
- University of Texas Rio Grande Valley
- Université de Strasbourg
- 42 more »
- « less
-
Field
-
myeloid leukemia (AML), and natural killer/T-cell lymphoma (NKTL). The successful candidate will contribute to projects utilizing genomics, transcriptomics, proteomics, and functional studies to identify
-
. The programme will use deeply phenotyped patient cohorts and blood, skin and gastrointestinal tissue samples, together with high-dimensional single-cell and bulk transcriptomics, immunohistochemistry, proteomics
-
in molecular biology techniques, RNA-omics and/or proteomics, and related bioinformatic analyses. Fluency in spoken and written English, as well as a strong track record of carrying out and finalizing
-
Goonewardena - whose work has appeared in leading journals including NEJM AI, JAMA, and Circulation - the program fuses artificial intelligence, advanced cardiac imaging, multiomics (proteomics, metabolomics
-
creating new opportunities for therapeutic discovery and development. We are particularly interested in candidates with expertise in biochemical, biophysical, cellular, structural, and/or proteomic
-
method development, data analysis, and experimental design. Integrate information from high-throughput screens, proteomic data, and next-generation sequencing data to generate and validate hypotheses
-
Design pipelines for image preprocessing, segmentation, feature extraction, and predictive modeling Collaborate with cross-functional teams to integrate imaging data with genomic/transcriptomic/proteomic
-
biomarkers through integrative computational analyses. · Analyze, integrate, and interpret genomic, transcriptomic, proteomic, imaging, and other high-dimensional biological datasets. · Develop reproducible
-
. · Analyze, integrate, and interpret genomic, transcriptomic, proteomic, imaging, and other high-dimensional biological datasets. · Develop reproducible computational workflows and data visualization
-
, CRISPR-based approaches, transfection/transduction, and in vitro bacterial infection models. Apply omics approaches (e.g., epigenomics, transcriptomics, proteomics) to support drug targetidentification and